Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
70 participants
INTERVENTIONAL
2018-09-01
2019-10-10
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy and Safety of Avanafil in the Patients With Erectile Dysfunction
NCT02477436
Research Evaluating a PDE5 Inhibitor for Erectile Dysfunction
NCT01698684
Research Evaluating an Investigational Medication for Erectile Dysfunction - General ED
NCT00790751
Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Avanafil
NCT00903981
Study the Effect of Avanafil on the Pharmacodynamics and Pharmacokinetics of Warfarin in Healthy Male Subjects
NCT01095588
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
intervention group
Males with sexual dysfunction who received daily avanafil tablets (50mg) for four weeks
Avanafil 50 MG
Oral phosphodiesterase type 5 inhibitors
control group
Males with sexual dysfunction who received daily placebo tablets for four weeks
Placebo oral tablet
lactose and maize starch, Egypt
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Avanafil 50 MG
Oral phosphodiesterase type 5 inhibitors
Placebo oral tablet
lactose and maize starch, Egypt
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Should be associated with systemic disorders indicative of endothelial dysfunction
Exclusion Criteria
18 Years
MALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Alexandria
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Shimaa Ismail Abdelhamid, MD
Principal investigator
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Abdelaal Elkamshoushi, MD
Role: STUDY_DIRECTOR
University of Alexandria
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Faculty of Medicine, Alexandria University.
Alexandria, Elazareta, Egypt
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Konstantinopoulos A, Giannitsas K, Athanasopoulos A, Spathas D, Perimenis P. The impact of daily sildenafil on levels of soluble molecular markers of endothelial function in plasma in patients with erectile dysfunction. Expert Opin Pharmacother. 2009 Feb;10(2):155-60. doi: 10.1517/14656560802678211.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol
Document Type: Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0105643
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.